Bucurica Sandica, Parolă Ioana, Vasile Alexandru Gavril, Maniu Ionela, Mititelu Mihaela-Raluca
Department of Gastroenterology, "Carol Davila" University of Medicine and Pharmacy Bucharest, 020021 Bucharest, Romania.
Department of Gastroenterology, "Dr. Carol Davila" Central Military Emergency University Hospital, 010825 Bucharest, Romania.
J Clin Med. 2025 Jan 2;14(1):212. doi: 10.3390/jcm14010212.
Hepatic hydrothorax (HH) is a severe cirrhosis complication requiring early diagnosis and appropriate management. This study aimed to assess the impact of HH on the disease severity and mortality of cirrhotic patients and compare their clinical and biological profiles with those of patients without HH. This retrospective study involved 155 patients diagnosed with cirrhosis, of whom 31 had HH. The diagnosis of HH was based on imaging techniques such as X-ray, ultrasound, and thoracic CT scans. The severity of cirrhosis was evaluated using the Child-Pugh, MELD, MELD-Na, and MELD 3.0 scoring systems. Of the included patients, 83.87% ( = 26) were men, with a 20% incidence of HH. The main etiology was chronic alcohol use. The pleural fluid localization revealed similar numbers of patients with bilateral and right pleural distribution. Patients with HH were predominantly classified in Child-Pugh-Turcotte class C. The MELD, MELD-Na, and MELD 3.0 scores had higher median values in the group of patients with hepatic hydrothorax. Still, death occurred at lower MELD scores when compared with cirrhotic patients without HH (MELD score > 22.5 for patients with HH vs. MELD > 32.5 for patients without HH). (The cirrhotic patients with HH presented lower serum albumin, cholesterol, and triglyceride levels and higher bilirubin, INR, and creatinine values. The mortality rate was higher in the group with HH-58,06% versus 20.97% in the control group (cirrhotics without HH). Hepatic hydrothorax is a serious complication of cirrhosis that requires early recognition and proper management, supported by using biomarkers and scoring systems.
肝性胸水(HH)是一种严重的肝硬化并发症,需要早期诊断和恰当处理。本研究旨在评估HH对肝硬化患者疾病严重程度和死亡率的影响,并将其临床和生物学特征与无HH的患者进行比较。这项回顾性研究纳入了155例诊断为肝硬化的患者,其中31例有HH。HH的诊断基于X线、超声和胸部CT扫描等影像学技术。使用Child-Pugh、MELD、MELD-Na和MELD 3.0评分系统评估肝硬化的严重程度。纳入患者中,83.87%(n = 26)为男性,HH发病率为20%。主要病因是长期酗酒。胸腔积液定位显示双侧和右侧胸腔分布的患者数量相似。有HH的患者主要归类为Child-Pugh-Turcotte C级。肝性胸水患者组的MELD、MELD-Na和MELD 3.0评分中位数较高。然而,与无HH的肝硬化患者相比,有HH的患者在较低的MELD评分时发生死亡(有HH的患者MELD评分>22.5,无HH的患者MELD>32.5)。(有HH的肝硬化患者血清白蛋白、胆固醇和甘油三酯水平较低,胆红素、INR和肌酐值较高。HH组的死亡率较高——58.06%,而对照组(无HH的肝硬化患者)为20.97%。肝性胸水是肝硬化的一种严重并发症,需要早期识别和恰当处理,可借助生物标志物和评分系统。